Profiling serine protease substrate specificity with solution phase fluorogenic peptide microarrays
- PMID: 15742319
- DOI: 10.1002/pmic.200401011
Profiling serine protease substrate specificity with solution phase fluorogenic peptide microarrays
Abstract
A novel microarray-based proteolytic profiling assay enabled the rapid determination of protease substrate specificities with minimal sample and enzyme usage. A 722-member library of fluorogenic protease substrates of the general format Ac-Ala-X-X-(Arg/Lys)-coumarin was synthesized and microarrayed, along with fluorescent calibration standards, in glycerol nanodroplets on microscope slides. The arrays were then activated by deposition of an aerosolized enzyme solution, followed by incubation and fluorometric scanning. The specificities of human blood serine proteases (human thrombin, factor Xa, plasmin, and urokinase plasminogen activator) were examined. The arrays provided complete maps of protease specificity for all of the substrates tested and allowed for detection of cooperative interactions between substrate subsites. The arrays were further utilized to explore the conservation of thrombin specificity across species by comparing the proteolytic fingerprints of human, bovine, and salmon thrombin. These enzymes share nearly identical specificity profiles despite approximately 390 million years of divergent evolution. Fluorogenic substrate microarrays provide a rapid way to determine protease substrate specificity information that can be used for the design of selective inhibitors and substrates, the study of evolutionary divergence, and potentially, for diagnostic applications.
Similar articles
-
High throughput substrate specificity profiling of serine and cysteine proteases using solution-phase fluorogenic peptide microarrays.Mol Cell Proteomics. 2005 May;4(5):626-36. doi: 10.1074/mcp.M500004-MCP200. Epub 2005 Feb 10. Mol Cell Proteomics. 2005. PMID: 15705970
-
Peptide microarrays for the determination of protease substrate specificity.J Am Chem Soc. 2002 Dec 18;124(50):14868-70. doi: 10.1021/ja027477q. J Am Chem Soc. 2002. PMID: 12475327
-
Ultrasensitive fluorogenic substrates for serine proteases.Thromb Haemost. 1997 Oct;78(4):1193-201. Thromb Haemost. 1997. PMID: 9364984
-
Coumarin and isocoumarin as serine protease inhibitors.Curr Pharm Des. 2004;10(30):3781-96. doi: 10.2174/1381612043382684. Curr Pharm Des. 2004. PMID: 15579071 Review.
-
Synthetic peptide substrates in hemostatic testing.Crit Rev Clin Lab Sci. 1983;19(2):71-134. doi: 10.3109/10408368309165760. Crit Rev Clin Lab Sci. 1983. PMID: 6373139 Review.
Cited by
-
Chemical microarray: a new tool for drug screening and discovery.Drug Discov Today. 2006 Jul;11(13-14):661-8. doi: 10.1016/j.drudis.2006.05.002. Drug Discov Today. 2006. PMID: 16793536 Free PMC article. Review.
-
A reactive center loop-based prediction platform to enhance the design of therapeutic SERPINs.Proc Natl Acad Sci U S A. 2021 Nov 9;118(45):e2108458118. doi: 10.1073/pnas.2108458118. Proc Natl Acad Sci U S A. 2021. PMID: 34740972 Free PMC article.
-
Plasmin activates epithelial Na+ channels by cleaving the gamma subunit.J Biol Chem. 2008 Dec 26;283(52):36586-91. doi: 10.1074/jbc.M805676200. Epub 2008 Nov 3. J Biol Chem. 2008. PMID: 18981180 Free PMC article.
-
Detection of Plasma Protease Activity Using Microsphere-Cytometry Assays with E. coli Derived Substrates: VWF Proteolysis by ADAMTS13.PLoS One. 2015 May 18;10(5):e0126556. doi: 10.1371/journal.pone.0126556. eCollection 2015. PLoS One. 2015. PMID: 25992814 Free PMC article.
-
Plasmin improves blood-gas barrier function in oedematous lungs by cleaving epithelial sodium channels.Br J Pharmacol. 2020 Jul;177(13):3091-3106. doi: 10.1111/bph.15038. Epub 2020 May 11. Br J Pharmacol. 2020. PMID: 32133621 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
